ArticleClinical pharmacology and therapeutics2014

CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicity.

M Roustit et al.PubMed ↗Publisher ↗

No numbers read from the abstract.